Legacy of Drug Patenting and Its Impact on Public Health
New drugs extend life and improve its quality. Drug patents provide an incentive to develop new drugs, but patented drugs are often expensive, and they block the sale of inexpensive generic copies. Generic firms have grown active in challenging the validity of drug patents over the past two decades, in an effort to enter the market prior to expiration of the patent. This paper examines these legal challenges and their effects on the entry of generic drugs and access to medicines. These analyses will help us to inform current policy debates about how well pharmaceutical patent laws and regulations balance innovation and access, and their effect on public health.
Authors
- Dr. Imran Ahad
Institutions
- Central University of Kashmir (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24413927
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00